Highlight Sessions

Scientific Program

Highlight Sessions

  • Keynote Lecture
  • Special Lecture
  • State-of-the-art Lecture

Day 2, November 18 (Fri) | 08:30 ~ 09:00

Room 3F-1

Gene editing and transplantation

Hiromitsu Nakauchi

(Stanford University, USA)

Bio Sketch

Hiromitsu Nakauchi is a physician scientist with a broad background in stem cell biology, hematology, and immunology, with specific training and expertise in in vivo approaches and molecular biology, within a long scientific career of innovative and high-impact research. His laboratory was responsible for establishing key methods for in vitro generation of human platelets and T cells for clinical transfusion and immunotherapy, respectively. Additionally, he established methods to generate complex solid organs from PSCs by using in vivo developmental organ niches. These diverse research achievements at the interface of stem cell biology, hematology, and immunology highlight his credentials of innovative and transformative research.

Day 1, November 17 (Thu) | 17:00 ~ 17:30

Room 3F-1

The Failing Allograft: Updates from The KDIGO Challenges Conference

Roslyn Mannon

(University of Nebraska, USA)

Bio Sketch

Roslyn Bernstein Mannon is a professor of medicine, pathology and microbiology at the University of Nebraska Medical Center, vice-chair for academic development and research mentoring, and associate chief of nephrology for research. She is a fellow of the American Society of Nephrology and the American Society of Transplantation. She received her medical degree from Duke University, completing an internal medicine internship, residency and nephrology fellowship and chief residency at Duke.

Day 2, November 18 (Fri) | 08:00 ~ 08:30

Room 3F-1

Present and future of mRNA vaccines

Eui Cheol Shin

(Korea Advanced Institute of Science and Technology (KAIST), Korea)

Bio Sketch

Eui-Cheol Shin received his M.D. (1996) and Ph.D. (2001) from Yonsei University, Seoul, Republic of Korea, and his postdoctoral training from Barbara Rehermann’s laboratory in National Institutes of Health, Bethesda, Maryland, USA. Then he joined Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea in 2007, where he is currently a professor. His laboratory, the Laboratory of Immunology and Infectious Diseases, performs researches on T cell responses in human viral disease and cancer.

Day 3, November 19 (Sat) | 13:30 ~ 14:00

Room 3F-1

Minimally Invasive Recipient Surgery

Kyung-Suk Suh

(Seoul National University, Korea)

Bio Sketch

Professor Kyung-Suk Suh is a Professor of Department of Surgery at Seoul National University College of Medicine. Professor Suh graduated from Seoul National University College of Medicine with his medical degree in 1984 and completed his internship and residency in Department of Surgery at Seoul National University Hospital, receiving his diploma in General Surgery in 1989. Since 2011, Professor Suh has been taking a number of roles, including Director of the International affairs in Korean Society of Organ Transplantation (2011-), Chairman in Korean Association of HBP Surgery(2015-2017), President of the International Living Donor Liver Transplantation Study Group(2015-2017) and Chairman of Korean Surgical Society(2016-2018). Professor Suh’s major fields of interest are liver transplantation, oncological surgery for hepato-biliary carcinoma and minimal invasive surgery.

Evolving Strategies in Living Donor Liver Transplantation for Hepatocellular Carcinoma

Chao-long Chen

(Kaohsiung Chang Gung Memorial Hospital, China)

Bio Sketch

Professor Chao-Long Chen is a pioneer liver transplant surgeon who performed the first successful liver transplantation in Asia in 1984, and by 2022, has accomplished 2200 more. He did the first split liver transplantation in Asia in 1997 and started the adult LDLT in Taiwan by 1999. Further, he performed the first dual graft LDLT in Taiwan in 2002, pioneered routine microsurgical biliary reconstruction in the world in 2006, and performed Taiwan’s first segment 2 monosegment LDLT in 2013. He was elected as Academician of the Chinese Academy of Engineering in 2007 and as President of the International LDLT Group in 2020-21. He remains director of one of the leading global centers in LDLT.